This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Mar;6(3):167.

doi: 10.1016/S2213-8587(18)30042-1.

Treatment of cystic fibrosis-related diabetes

Laurence Kessler¹

Affiliations

Affiliation

¹ Service d'Endocrinologie, Diabète et Nutrition, Hôpitaux Universitaires de Strasbourg, Hôpital Civil, 67000 Strasbourg, France; INSERM UMR 1260, Nano Médecine Régénérative, Fédération de Médecine Translationnelle, Université de Strasbourg, Strasbourg, France. Electronic address: laurence.kessler@chru-strasbourg.fr.

PMID: 29475494
DOI: 10.1016/S2213-8587(18)30042-1

Comment

Treatment of cystic fibrosis-related diabetes

Laurence Kessler. Lancet Diabetes Endocrinol. 2018 Mar.

. 2018 Mar;6(3):167.

doi: 10.1016/S2213-8587(18)30042-1.

Author

Laurence Kessler¹

Affiliation

¹ Service d'Endocrinologie, Diabète et Nutrition, Hôpitaux Universitaires de Strasbourg, Hôpital Civil, 67000 Strasbourg, France; INSERM UMR 1260, Nano Médecine Régénérative, Fédération de Médecine Translationnelle, Université de Strasbourg, Strasbourg, France. Electronic address: laurence.kessler@chru-strasbourg.fr.

PMID: 29475494
DOI: 10.1016/S2213-8587(18)30042-1

No abstract available

PubMed Disclaimer

Comment in

Treatment of cystic fibrosis-related diabetes - Authors' reply.
Ballmann M, Holl RW. Ballmann M, et al. Lancet Diabetes Endocrinol. 2018 Mar;6(3):167-168. doi: 10.1016/S2213-8587(18)30043-3. Lancet Diabetes Endocrinol. 2018. PMID: 29475493 No abstract available.

Comment on

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.
Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW; CFRD Study Group. Ballmann M, et al. Lancet Diabetes Endocrinol. 2018 Feb;6(2):114-121. doi: 10.1016/S2213-8587(17)30400-X. Epub 2017 Dec 5. Lancet Diabetes Endocrinol. 2018. PMID: 29199116 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- Genetic Alliance
- MedlinePlus Health Information